Cipla and Qilu Are Preparing a Biosimilar Challenge to Keytruda

India's Cipla and China's Qilu Pharmaceutical have partnered to bring a biosimilar version of Merck's cancer drug Keytruda to the U.S. market. Biosimi…

Continue in Briflio to read, react, comment, and share.